UCLA Researchers Identify Vulnerability in Aggressive Cancers, Offering New Treatment Pathways
Researchers at UCLA have discovered a previously hidden vulnerability in some of the most aggressive cancers, such as small cell neuroendocrine cancers, which can develop in the lungs, prostate, and ovaries. These cancers are known for their rapid growth, early spread, and resistance to treatment. A key characteristic of these cancers is the loss of the RB gene, which normally regulates cell growth. The absence of RB allows cancer cells to multiply unchecked and evade targeted therapies. The study, published in the Proceedings of the National Academy of Sciences, reveals that the loss of RB makes these cancer cells heavily reliant on a protein called E2F3. By blocking E2F3, researchers were able to stop tumor growth in laboratory experiments, suggesting a new potential treatment strategy. 
